Literature DB >> 19347013

Mechanisms of HCV survival in the host.

Ella H Sklan1, Prista Charuworn, Philip S Pang, Jeffrey S Glenn.   

Abstract

HCV infection is an important cause of liver disease worldwide-nearly 80% of infected patients develop chronic liver disease, which leads to the development of liver cirrhosis and hepatocellular carcinoma. The ability of HCV to persist within a host is believed to be related to the numerous mechanisms by which it evades the immune response of the host. These mechanisms can be divided into defensive and offensive strategies. Examples of defensive mechanisms include replication within enclosed structures, which provides protection from the host's antiviral defenses, genetic diversity created by inaccurate replication, which yields mutants resistant to the cell's antiviral strategies, and association of the virion with protective lipoproteins. Offensive mechanisms include virally encoded proteins and other factors that disrupt the ability of the host cells to detect the virus and downregulate its ability to respond to interferon, impair innate immune defense mechanisms and alter T-cell responses, and prevent the development of an effective B-cell-mediated humoral response. Greater understanding of these viral survival strategies will ultimately translate into more effective antiviral therapies and better prognosis for patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19347013     DOI: 10.1038/nrgastro.2009.32

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


  105 in total

Review 1.  Altered innate immunity in chronic hepatitis C infection: cause or effect?

Authors:  Gyongyi Szabo; Serena Chang; Angela Dolganiuc
Journal:  Hepatology       Date:  2007-10       Impact factor: 17.425

2.  Replication strategy of Kunjin virus: evidence for recycling role of replicative form RNA as template in semiconservative and asymmetric replication.

Authors:  P W Chu; E G Westaway
Journal:  Virology       Date:  1985-01-15       Impact factor: 3.616

3.  Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1).

Authors:  Michiko Miyamoto; Takanobu Kato; Tomoko Date; Masashi Mizokami; Takaji Wakita
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

4.  Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.

Authors:  Emily C Baechler; Franak M Batliwalla; George Karypis; Patrick M Gaffney; Ward A Ortmann; Karl J Espe; Katherine B Shark; William J Grande; Karis M Hughes; Vivek Kapur; Peter K Gregersen; Timothy W Behrens
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

5.  Pervasive influence of hepatitis C virus on the phenotype of antiviral CD8+ T cells.

Authors:  Michaela Lucas; Ana L Vargas-Cuero; Georg M Lauer; Eleanor Barnes; Christian B Willberg; Nasser Semmo; Bruce D Walker; Rodney Phillips; Paul Klenerman
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

6.  Hepatitis C virus non-structural proteins in the probable membranous compartment function in viral genome replication.

Authors:  Yusuke Miyanari; Makoto Hijikata; Masashi Yamaji; Masahiro Hosaka; Hitoshi Takahashi; Kunitada Shimotohno
Journal:  J Biol Chem       Date:  2003-09-08       Impact factor: 5.157

7.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

8.  Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection.

Authors:  N Enomoto; I Sakuma; Y Asahina; M Kurosaki; T Murakami; C Yamamoto; Y Ogura; N Izumi; F Marumo; C Sato
Journal:  N Engl J Med       Date:  1996-01-11       Impact factor: 91.245

9.  Presence of functional dendritic cells in patients chronically infected with hepatitis C virus.

Authors:  Randy S Longman; Andrew H Talal; Ira M Jacobson; Matthew L Albert; Charles M Rice
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

10.  Functional properties of a monoclonal antibody inhibiting the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Darius Moradpour; Elke Bieck; Thomas Hügle; Winfried Wels; Jim Zhen Wu; Zhi Hong; Hubert E Blum; Ralf Bartenschlager
Journal:  J Biol Chem       Date:  2001-10-18       Impact factor: 5.157

View more
  20 in total

Review 1.  Mixing the right hepatitis C inhibitor cocktail.

Authors:  Michael A Gelman; Jeffrey S Glenn
Journal:  Trends Mol Med       Date:  2010-11-23       Impact factor: 11.951

Review 2.  Host genetic basis for hepatitis C virus clearance: a role for blood collection centers.

Authors:  Suganya Selvarajah; Leslie H Tobler; Graham Simmons; Michael P Busch
Journal:  Curr Opin Hematol       Date:  2010-11       Impact factor: 3.284

3.  Regulation of host innate immunity by hepatitis C virus: crosstalk between hepatocyte and NK/DC.

Authors:  Sung-Jae Park; Young S Hahn
Journal:  Rev Infect       Date:  2010-07-01

Review 4.  Common threads in persistent viral infections.

Authors:  Melissa Kane; Tatyana Golovkina
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

5.  What is the Risk of Graft Reinfection in Case of Liver Transplantation for Patients With Acute HEV or HAV Infection?

Authors:  Anil C Anand; Neerav Goyal; Hitendra K Garg; Shaleen K Agarwal; Sudeep Khanna; Subhash Gupta
Journal:  J Clin Exp Hepatol       Date:  2016-09-22

6.  Antigenic cooperation among intrahost HCV variants organized into a complex network of cross-immunoreactivity.

Authors:  Pavel Skums; Leonid Bunimovich; Yury Khudyakov
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

7.  Activation of natural killer cells during acute infection with hepatitis C virus.

Authors:  Barbara Amadei; Simona Urbani; Angelica Cazaly; Paola Fisicaro; Alessandro Zerbini; Parvin Ahmed; Gabriele Missale; Carlo Ferrari; Salim I Khakoo
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

8.  Genomic scale analysis of racial impact on response to IFN-alpha.

Authors:  Zoltan Pos; Silvia Selleri; Tara L Spivey; Jeanne K Wang; Hui Liu; Andrea Worschech; Marianna Sabatino; Alessandro Monaco; Susan F Leitman; Andras Falus; Ena Wang; Harvey J Alter; Francesco M Marincola
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

9.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

Review 10.  Targeting the inflammation in HCV-associated hepatocellular carcinoma: a role in the prevention and treatment.

Authors:  Giuseppe Castello; Susan Costantini; Stefania Scala
Journal:  J Transl Med       Date:  2010-11-03       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.